Acute promyelocytic leukemia · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Arsenic trioxide and Idarubicin Variant #01 | — | R 246 254 | 60d | — | — | ~1 | ~R 246 254 indirect | — |
Arsenic trioxide monotherapy Variant #01 | — | R 39 096 | 60d | — | — | ~6 | ~R 234 574 indirect | — |
Tamibarotene monotherapy Variant #01 Partial | — | — | 56d | — | — | ~1 | — | — |
3 of 3 regimens shown